BioCentury
ARTICLE | Company News

CombinatoRx autoimmune, cancer, inflammation news

November 10, 2008 8:00 AM UTC

CombinatoRx restructured and reduced headcount across the company by about 50 (45%) to 90 to conserve cash. The company is seeking partners for its clinical compounds Synavive ( CRx-102), CRx-401, CR...